A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants

Clinical trial NCT03922633 · COMPLETED

Trial details

NCT number: NCT03922633
Sponsor: EA Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Participants

Start date: 2019-04-22
Primary completion: 2020-05-20
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.